Preclinical trials are critical in developing new medicines that ease the suffering of society. Today, firms must plan preclinical research for global acceptance.
However, they face challenges in this regard. These challenges include:
Historically, firms have relied on on-premises informatics. On-premises systems have become outdated. What’s more, they’re inefficient and expensive. On-premises architecture requires considerable investment in several areas, such as: